Regenxbio (RGNX) Invested Capital (2014)

Regenxbio's (RGNX) quarterly Invested Capital came in at $1.4 million in Q4 2014.

Regenxbio (RGNX) Invested Capital (2014) Analysis & Trends

Regenxbio's Invested Capital history runs 1 years deep, the most recent figure standing at $1.4 million for Q4 2014.

  • On a quarterly basis, Invested Capital changed N/A year-over-year to $1.4 million in Q4 2014; TTM through Sep 2015 was $1.4 million, a N/A change from a year earlier, with the FY2014 full-year figure at $1.4 million, changed N/A from the prior year.
  • Invested Capital was little changed at $1.4 million in Q4 2014 per RGNX's latest filing.
  • Across five years, Invested Capital topped out at $1.4 million in Q4 2014 and bottomed at $1.4 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.96 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 116.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Regenxbio 528.62 Mn 298.55 Mn 21.22 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2014 1.42 Mn